NCT02738853View on ClinicalTrials.gov

The Medtronic TAVR 2.0 US Clinical Study

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 15, 2021

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Medtronic Transcatheter Aortic Valve 2.0 Replacement System

Treatment of severe symptomatic aortic stenosis in subjects who are considered at high through extreme risk for surgical aortic valve replacement.

Trial Locations (8)

10016

NYU / Langone Medical Center, New York

10032

New York-Presbyterian Hospital / Columbia University Medical Center, New York

43214

OhioHealth Riverside Methodist Hospital, Columbus

66160

The University of Kansas Hospital, Kansas City

77030

Houston Methodist Hospital, Houston

06520

Yale-New Haven Hospital, New Haven

02215

Beth Israel Deaconess Medical Center, Boston

07960

Morristown Memorial Hospital, Morristown

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT02738853 - The Medtronic TAVR 2.0 US Clinical Study | Biotech Hunter | Biotech Hunter